Samsung BioLogics, however, argued that it abided by accounting rules, and that the 2015 gains were the result of adhering to IFRS accounting standards. Samsung BioLogics had at the time changed the status of its biosimilar-making unit Samsung Bioepis into an affiliate, citing the possibility of
See Original Article

Other strategists are starting to catch up to Morgan Stanley. The median mid-year forecast for the U.S. Dollar Index has jumped to 90.70 from 89.20 at the end of March. The greenback has been the strongest major currency over the past three months, with the Bloomberg Correlated-Weighted Index of the
See Original Article

Jeff Bezos has so much money he doesn't know what to do with it all, so he figures he'd might as well spend it on spaceships.
See Original Article

An initial investment of $100,000 in the Templeton Emerging Markets Fund in 1987 was worth about $3.3 million in 2015, according to data compiled by Bloomberg. However, 11 of the 13 largest funds Mobius oversaw at that stage had underperformed benchmarks over the five years through the early
See Original Article

Apple had promised for more than a year that it would return overseas cash to investors if tax laws changed. Photo: Eric Thayer/Getty Images.
See Original Article